DHSC:SCI: support for a review of voluntary scheme for branded medicines
⢠The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) is a rebate scheme on the pharmaceutical industry which generates income for the NHS and controls the bottom line of the NHS budget. This is critical to the financial sustainability of the NHS by controlling how much the NHS spends on branded drugs - this is one of the largest commercial agreements in Government. VPAG also includes important elements that support the wider medicines environment, including supporting greater and timeli...
Buyer
Department of Health and Social Care
Value
£99,600
Published
22 May 2025
Closes
13 Apr 2025
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Services
Contract starts
13 Apr 2025
Contract ends
15 Jul 2025
CPV classifications
72224000
Project management consultancy services
Lots
Lot default DHSC:SCI: support for a review of voluntary scheme for branded medicines
£99,600
⢠The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) is a rebate scheme on the pharmaceutical industry which generates income for the NHS and controls the bottom line of the NHS budget. This is critical to the financial sustainability of the NHS by controlling how much the NHS spends on branded drugs - this is one of the largest...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
22 May 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
VPAG contract April 2025 fully signed_Redacted
Not provided
VPAG contract April 2025 fully signed_Redacted
Contains public sector information licensed under the Open Government Licence v3.0.